BioNexus Gene Lab
BGLC
#11183
Rank
A$3.56 M
Marketcap
A$1.22
Share price
-9.43%
Change (1 day)
-83.04%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): A-$1.61

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is A-$1.60. In 2025 the company made an earnings per share (EPS) of A-$2.38 a decrease over its 2024 EPS that were of A-$1.33.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.61-32.11%
2025A-$2.3879.15%
2024A-$1.33-45.96%
2023A-$2.46260.87%
2022A-$0.68-195.83%
2021A$0.71-66.67%
2020A$2.13-600.17%
2019A-$0.43-1031.69%
2018A$0.04574

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.00 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA